HONG KONG, June 29, 2017 -- iView Limited (hereinafter referred to as “iView”), a major global pico-projection engine provider, has recently completed its series B funding round valued at over RMB 100 million. CMS Zhiyuan Capital Co., Ltd. (hereinafter referred to as “CMS Zhiyuan Capital”), an investment platform of China Merchants Securities (CMS), was the lead investor during this round of funding.
|
|||||
Founded in 2006, iView is composed of a team of industrial veterans with solid backgrounds in the fields of display, optics and semiconductor, and material science. The company is committed to the research and development of optoelectronics and pico-projection, the commercialization of research and development results, as well as the consumer goods and application in industrial fields. iView has long excelled in the industry and its main clients include well-known providers of projectors, projector phones, and HUD for automotive.
CMS Zhiyuan Capital, the leading investor of this round, thinks highly of the broad prospects of the pico-projector industry and the vast development potential of iView. As one of the major providers of pico-projection core devices, iView ranks top in the industry for its technological strength and market share. While promoting the application of pico-projection in home entertainment, iView also focuses on further achieving high-definition and miniaturization of pico-projectors, launching “Projection +” by integrating with other fields, which include mobile electronics, automobile electronics and smart homes. Now, mature solutions are in place and international and domestic partnerships have been established.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f3a819ed-267e-40da-a358-73fbdf26f6fa
Funds raised from this round will be used primarily for research and development and for boosting industrial capacity, iView will continue to expand the new application scenarios of pico-projection technology in order to meet the corresponding demands. CMS Zhiyuan Capital will share resources, provide iView with comprehensive value-added services, utilize the full range of financial services of the CMS industry chain and foster an early entry into the domestic capital market for the company.
About iView Limited
Headquartered in Hong Kong, iView’s design and production center is located in Shenzhen, China. It is a leading optoelectronic pico-projection component supplier, providing multiple international brands with optoelectronic pico-projectors. The general product series include micro-components embedded in mobile devices, mobile phone driver parts and high-power components for home entertainment and office use. Apart from consumer electronics, products of iView have also been applied to industrial and medical purposes such as head-up display for cars, 3D scanner and printers and medical vein finders.
Contact: Daniel Kong Email: [email protected]


Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



